You are here

NIMHANS Uses Simulation from Dassault Systémes in its Research to Improve Efficacy of Medical Treatment through Neuromodulation

By chandu Created on 10/11/2018 - 19:31 . Updated 10/11/2018 - 19:54

. NIMHANS adopts Dassault Systémes‘ SIMULIA applications powered by the 3DEXPERtENCE platfon'n

. Accurate simulations could potentially help medical professionats forecast

challenges and outcomes of treatment procedures for patients with schizophrenia

First-of-a-kind deployment announced at Dassault Systémes‘ first ever local edition of its global event Science In the Age of Experience In India

Bengaluru, IndiaOctober 2018 -Dassault Systemes (Euronext Paris: #13065. DSYPA) announced that National Institute of Mental Health & Neuro Sciences (NIMHANS). the apex center for mental health and neuroscience eduoation in India. has deployed Dassault Systemes‘ SIMULIA applications to predict the efficacy of Transcranial Direct Current Stimulation (tDCS). a non-invasive clinical treatment for schizophrenia patients, virtually before the clinical procedure. The announcement was made at Dassault Systemes‘ first ever local edition of its global event Science in the Age of Experience in India that aims to showcase the c0mpany’s simulation applications in transportation, aerospace and life sciences venicals.

NIMHANS’s adoption of SIMULIA applications powered by the 3DEXPERIENCE platform is a first-ot-its-kind deployment, where psychiatrists at NIMHANS wit! be able to teverage simulation technology to forecast challenges and outcomes of the treatment procedure for disorders such as schizophrenia. With SIMULIA applications. the team envisages the potential to develop a conceptual non-invasive method for Deep Brain Stimulation.

Dr. Dr. G. Venkatasubramanian, MD PhD, Professor of Psychiatry. Head. Department of Clinical Neurosciences at NIMHANS, “Computational modelling and simulation technologies allow mathematical reconstruction of the impact of tDCS in the treatment of several neuropsychiatric disorders. With multiphysics simulation capabilities on the 3DEXPERINCE platform, under the WISER Neuromodulation Program at the National Institute of Mental Health and Neurosciences. patient-speciftc finite element models of the brain are used to accurately estimate the Iikely impact of electrical stimulation for treating the symptoms of schizophrenia. Which, in turn can facilitate personalized neuromodulation.‘

At the announcement. Samson Khaou, Managing Director, India, Dassault Systémes said. "The biggest challenge faced today by the healthcare sector in India Is the absence of a standard procedure to predict the effectiveness of a treatment for various chronic diseases. As the life sciences industry moves towards more ‘personalized healthcare', custom-made simulations allow for more precise analyses and predictions of human body dynamics. With Dassault Syst‘emes' SIMULIA and BIOVIA applications on the 3DEXPERIENCE platform. we aim to bridge this gap by enabling our customers develop new and innovative methods for patients treatment.‘